4.6 Review

The roles of the Hippo pathway in cancer metastasis

Journal

CELLULAR SIGNALLING
Volume 28, Issue 11, Pages 1761-1772

Publisher

ELSEVIER SCIENCE INC
DOI: 10.1016/j.cellsig.2016.08.004

Keywords

Hippo pathway; Tumour suppressor; Metastasis; EMT; Cell migration; Cancer

Categories

Funding

  1. Canadian Institute of Health Research (CIHR)
  2. Canadian Breast Cancer Foundation (CBCF)

Ask authors/readers for more resources

Cancer metastasis refers to the sequence of events whereby tumour cells detach from their primary tissue, invade and migrate to nearby vasculature, intravasate into circulation, survive in circulation and extravasate at a distant site to establish a secondary tumour. Each step in this metastatic cascade is coordinated by complex molecular events that remain only incompletely understood. Given that the vast majority of cancer fatalities occur due to metastasis, there is an urgent need for an improved understanding of the specific mechanisms underlying cancer metastasis and for the development of therapeutics targeting this lethal process. The Hippo pathway is an emerging signaling pathway that plays important roles in development and disease. In cancer cells, dysregulation of the Hippo pathway drives multiple aspects of tumour initiation and progression. Recent studies have uncovered a role for the Hippo pathway core components in promoting cancer metastasis. In this review, we summarize the clinical and biochemical evidence implicating the Hippo pathway in metastasis. Additionally, we describe the molecular mechanisms by which aberrant Hippo signaling promotes metastasis. Finally, we highlight areas for future research. (C) 2016 Elsevier Inc. All rights reserved.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available